Summary: Exciting news about using stem cells to treat blindness.
Air Date: 12/14/15
Host: Robert Abel, Jr., MD
Guest Bio: Steven Levy, MD
Dr. Steven Levy transitioned into life science and healthcare business development following 18 years in the practice of ophthalmology. Located in Connecticut, he serves as the CEO of the newly formed thought imaging company Millennium Magnetic Technologies, LLC.
He serves as President of the Acoma Group which provides business development and executive search services for bio-pharmaceutical, medical and healthcare companies globally. He is also President of MD Stem Cells, a leading provider of adult stem cell patient facilitation services for various diseases including those affecting the eye and through that position acts as Director for the NIH registered clinical study SCOTS- Stem Cell Ophthalmology Treatment Study. He is CEO of an emerging neuroimaging company called Millennium Magnetic Technologies.
Dr. Levy is an adjunct professor at Norwalk Community College. He has served as Chief Medical Officer for Impose Technologies, a prominent Health Information Technology, DICOM & PACS provider and is a consultant with Gerson-Lehrman, providing advice within the clinical and life sciences. Dr. Levy is strongly focused on early stage companies and enhancing their development from innovation to fundraising to networking.